#$%^&*AU2017248462B220191010.pdf#####ABSTRACT Disclosed are yeast-based immunotherapeutic compositions comprising mucin-I (MUC1), as well as methods for the prevention and/or treatment of cancers characterized by the expression or overexpression of mucin-1 (MUC1).